Integrated pharmacokinetics, pharmacodynamics, and clinical data update from phase 0/1 trial for BDTX-1535 in newly-diagnosed and recurrent glioblastoma patients with EGFR alterations.

silevertinib (BDTX-1535) - Black Diamond Therap

https://virtual.oxfordabstracts.com/event/74646/submission/276

Nader Sanai; Yoshie Umemura; Vahuni Karapetyan; Tigran Margaryan; Dylan Huttenlocher; Brian Pham; Jocelyn Harmon; Amy Hong; An-Chi Tien; Artak Tovmasyan; Shwetal Mehta

Dec 2, 2025